HONGCHANG INTERNATIONAL CO., LTD |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2226 USD | -.--% |
|
-.--% | -36.18% |
| Apr. 01 | Hongchang International Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Apr. 01 | Hongchang International Co., Ltd Announces Board Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Hongchang International Co Ltd, formerly Heyu Biological Technology Corp, is a holding company mainly engaged in research and development and manufacture a medical product, the Submillimeter Wave (Terahertz) Quantized Space Therapy Chamber (the Chamber). Utilizing submillimeter waves, the Chamber is a medical equipment designed to treat cancer through cold nuclear fusion caused by cosmic ray muons in an enclosed chamber.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -36.18% | 115M | |
| +25.74% | 661B | |
| +26.74% | 566B | |
| -6.75% | 352B | |
| +19.47% | 332B | |
| +3.28% | 283B | |
| +13.43% | 231B | |
| +4.71% | 200B | |
| -9.53% | 195B | |
| -4.23% | 145B |
- Stock Market
- Equities
- HCIL Stock
- News Hongchang International Co., Ltd
- Insider Buy: Heyu Biological Technology
